Abstract
Introduction Multimorbidity is an important public health challenge in ageing societies. While most multimorbidity research takes a cross-sectional approach, longitudinal approaches to understanding multimorbidity are an emerging research area. We aim to scope the methodological approaches and substantive findings of studies analysing multimorbidity trajectories.
Methods We identified studies employing longitudinal methodologies to explore multimorbidity trajectories using a scoping review approach. A systematically search for relevant studies was carried via four academic databases (Medline, Scopus, Web of Science, and Embase) complemented by professional networks and reference lists.
Results Our review identified 34 studies investigating multimorbidity longitudinally, all published in the last decade, and with a clear lack of research based on low- and middle-income country data. Longitudinal approaches included constructing variables of change, multilevel regression analysis (e.g. growth curve modelling), longitudinal group-based methodologies (e.g. latent class modelling), analysing disease transitions, and visualisation techniques. Commonly identified risk factors for multimorbidity onset and progression were older age, higher deprivation, overweight, and poorer health behaviours.
Conclusion The nascent research area employs a diverse range of longitudinal approaches that characterize accumulation and disease combinations, and to a lesser extent disease sequencing and progression. Understanding the life course determinants of different multimorbidity trajectories across diverse populations and settings can provide a detailed picture of morbidity development, with important implications from a clinical and intervention perspective.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Academy of Medical Sciences (AMS), the Wellcome Trust, the Government Department of Business, Energy and Industrial Strategy (BEIS), the British Heart Foundation Diabetes UK, and the Global Challenges Research Fund (GCRF) [Grant number SBF004\1093 awarded to Katherine Keenan].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was no required since this research systematically reviews published studies of multimorbidity trajectory research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The selected studies are available through academic databases (Medline, Scopus, Web of Science, and Embase).